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Abstract
Pulmonary surfactant is composed of approx. 90% lipids and 10% protein. This review article focusses on the lipid
components of surfactant. The first sections will describe the lipid composition of mammalian surfactant and the techniques
that have been utilized to study the involvement of these lipids in reducing the surface tension at an air-liquid interface, the
main function of pulmonary surfactant. Subsequently, the roles of specific lipids in surfactant will be discussed. For the two
main surfactant phospholipids, phosphatidylcholine and phosphatidylglycerol, specific contributions to the overall surface
tension reducing properties of surfactant have been indicated. In contrast, the role of the minor phospholipid components
and the neutral lipid fraction of surfactant is less clear and requires further study. Recent technical advances, such as
fluorescent microscopic techniques, hold great potential for expanding our knowledge of how surfactant lipids, including
some of the minor components, function. Interesting information regarding surfactant lipids has also been obtained in
studies evaluating the surfactant system in non-mammalian species. In certain non-mammalian species (and at least one
marsupial), surfactant lipid composition, most notably disaturated phosphatidylcholine and cholesterol, changes drastically
under different conditions such as an alteration in body temperature. The impact of these changes on surfactant function
provide insight into the function of these lipids, not only in non-mammalian lungs but also in the surfactant from mammalian
species. ß 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
A major function of pulmonary surfactant is to
reduce surface tension at the air-water interface of
the terminal airways, thereby decreasing the tendency
for alveolar collapse. It was surfactant’s ability to
reduce surface tension and thereby increase compli-
ance (i.e., elasticity) of the excised lung that led to its
initial discovery by von Neergaard in the 1920s [1].
This was truly a ‘premature’ discovery [2,3] which
exceeded the scienti¢c and medical communities’ ca-
pacity to appreciate its signi¢cance. Von Neergaard
clearly understood that the lining layer of the lung
possessed special surface properties superior to those
of adsorbed serum. Whether he understood that
phospholipids, or even lipids, were involved is not
clear. Von Neergaard also recognized the importance
of low surface tension for the newborn lung.
Surfactant’s capacity for reducing surface tension
also led to its rediscovery in the mid-1950s by Pattle
[4] and Clements [5]. These early surfactologists not
only recognized the ability of pulmonary surfactant
to adsorb and spread rapidly to form an insoluble
surface ¢lm, but also demonstrated that reductions in
surface area resulted in a corresponding fall in sur-
face tension to surprising if not unprecedented low
values. By this time, the ability of lipids to act as
surface tension reducing agents was well recognized.
Lecithin, or phosphatidylcholine (PC), had been dis-
covered as a component of egg yolk in 1847. The
presence of the disaturated lecithin, dipalmitoylphos-
phatidylcholine (DPPC) in lung tissue had been re-
ported in 1946 [6]. Although Pattle initially intuited
that pulmonary surfactant was an insoluble protein
¢lm [7], further studies soon established that phos-
pholipids comprised the major surface tension reduc-
ing component and DPPC was a major constituent
[8^10].
The rediscovery of pulmonary surfactant did not
go unnoticed by physicians concerned with RDS. In
1959, Avery and Mead were able to report saline
extracts of lungs from premature infants succumbing
to RDS were surfactant de¢cient compared to in-
fants dying of other causes [11]. This discovery
spurred enormous interest in the topic of this dedi-
cated issue.
This review will discuss the roles of the lipid com-
ponents of pulmonary surfactant. Although accom-
plished in cooperation with the surfactant-associated
proteins (SP-A, SP-B, and SP-C), it is the lipids that
are ultimately responsible for surface tension reduc-
tion to low value during inhalation and expiration
(see chapters by Goerke, Schu«rch and by Perez-Gil
and Keough for further details on the roles of sur-
factant proteins). Furthermore, although it has never
been demonstrated chemically, considerable circum-
stantial evidence implies that a surface monolayer
highly enriched in DPPC is responsible for the crit-
ical reduction in surface tension to values near 0 mN/
m that facilitates lung expansion at birth and allows
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regular breathing throughout life. The roles of the
other lipid components of pulmonary surfactant are
less well understood. This is particularly true with
surfactants recovered from non-mammalian species.
This review will try to present our best ‘educated
guesses’ as to these roles and suggest potential ways
of limiting the guesswork in the future. Due to lim-
ited space, other chapters in this dedicated issue and
previous reviews will be used liberally to document
evidence for some concepts and as sources of original
references. In addition, in many cases only the most
recent, key reference will be cited. Readers can use
these publications to ¢nd references to earlier work.
2. Composition
The overall lipid and phospholipid compositions
of surfactants isolated from a number of experimen-
tally used species (mouse, rat, rabbit, and sheep), of
bovine surfactant (which is used clinically), and of
human surfactant are listed in Table 1. The authors
are more impressed with the similarities than the
di¡erences. It is noteworthy that the lipid composi-
tion of lamellar bodies, the storage form of surfac-
tant, is very similar to those given in Table 1. In all
species, PC comprises approx. 80%, about half of
which is DPPC. Palmitic acid is a 16 carbon acyl
chain with no double bonds. Virtually no other di-
saturated PC species have been observed. Thus,
about 40% of the total phospholipid in mammalian
surfactant is composed of DPPC. Recent studies on
surfactant from neonatal calves reported DPPC ac-
counted for only 32% of the total phospholipid [12].
Although high DPPC levels have long been consid-
ered a hallmark of pulmonary surfactant, DPPC ac-
counts for 10^20% of the phosphatidylcholine con-
tent of brain myelin and erythrocyte membranes
[13,14].
The discrepancy between disaturated PC levels giv-
en here and some previous reports suggesting higher
levels may have arisen in part from the use of di¡er-
ent techniques to measure disaturated lipids. For ex-
ample, it has been reported that the osmium tetrox-
ide method of Mason [15] also detects some
monoenoic (one double bond) species. This leads to
arti¢cially high estimates of disaturated PC [16]. It
should also be recognized that not all of the DPPC
in lungs is in surfactant. In rat and ovine lungs, only
25 and 40%, respectively, of the DPPC is surfactant
associated [13,14].
The remaining PC in surfactant is composed pri-
marily of molecular species containing monoenoic
and dienoic fatty acids at the 2-position, with only
minor amounts of short chains or polyunsaturated
acyl groups. The acidic phospholipids, phosphatidyl-
Table 1
Lipid composition of extracellular surfactant in selected mammalian species
Phospholipid composition (% total) [% disaturated] Cholesterol (% chol/PL)
PC LPC SM PG PI PS PE LBPA
Mus musculus 72.3 0 3.3 18.1 1.9 9.7a
Mousea
Rattus norvegicus 82.3 0.3 0.8 7.5 1.8 0.1 5.1 Tr 7.1e
Ratb [49.3] [32.3] [2.2]
O. cuniculus 80.6 Tr 1.5 7.2 4 1.9 4.4 Tr
Rabbitb [52.8] [38.7] [2.5]
Ovis spp. 81 Tr 1.7 7.9 2.6 Tr 4.8 2
Ovinec
Bos spp. 79.2 Tr Tr 11.3 1.8 Tr 3.5 2.6 3
Bovined [49.9] [33.3]
Homo sapiens 80.5 Tr 2.7 9.1 2.6 0.9 12.3 7.3e
Humanc [47.7]
PC, phosphatidylcholine; LPC, lysophosphatidylcholine; SM, sphingomyelin; PG, phosphatidylglycerol ; PI, phosphatidylinositol ; PS,
phosphatidylserine; PE, phosphatidylethanolamine; LBPA, lyso-bis-phosphatidic acid; PL, phospholipid; chol, cholesterol ; Tr, trace.
(In some cases, the authors have added ‘trace’ on the basis of their experience.)
Data from: aLangman et al., 1996 [71]; bAkino, 1992 [14]; cPossmayer, 1984 [13]; dYu et al., 1983 [78]; eDaniels et al., 1995 [65].
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glycerol (PG) and phosphatidylinositol (PI), account
for 8^15% of the total surfactant phospholipid pool
with most species. Adult surfactants are depicted in
Table 1, so PG is high while PI is low. With surfac-
tant from fetal and neonatal lung, PI levels are ele-
vated and PG correspondingly lower. With some an-
imals, such as the rhesus monkey, PI remains high
into adult life. PG possesses a signi¢cant amount of
disaturated lipids, although not as much as PC.
However, this accounts for only a small part of the
total disaturated phospholipid pool. In contrast, PI
contains very low amounts of disaturated compo-
nents, although this remains somewhat controversial
[14].
The remaining phospholipids are present in rather
small amounts. Except for the human, phosphatid-
ylethanolamine (PE) is low with only 3^5% being
present. The other phosphorus-containing phospho-
lipids are present at very low levels. While they could
represent contaminants arising from membrane lip-
ids, the levels are quite consistent from one prepara-
tion to another and from species to species. The low
phosphatidylserine (PS) level is not surprising in view
of the known role of PS in triggering blood clotting
reactions and in apoptosis [17].
Less information is available concerning the neu-
tral lipid components of pulmonary surfactant. In
those mammalian species reported, cholesterol ap-
pears to be the major component (80^90%). Small
amounts of monoacylglycerol, diacylglycerol, and tri-
acylglycerol are present with most species. Cholester-
ol esters appear to be low in most species [13,18].
Most surfactants appear to have some free fatty
acids, mainly palmitate.
3. Methodology
3.1. Techniques for studying surfactant activity
Pulmonary surfactant is a unique biological system
in that a major function involves the rapid formation
of a highly surface-active ¢lm with an equilibrium
surface tension of approx. 25 mN/m (see below).
Furthermore, during breathing this ¢lm is subject
to dynamic compression, resulting in lateral packing
of the ¢lm to produce further lowering to near 0 mN/
m. As a result, most of the information on the func-
tional aspects of pulmonary surfactant have emerged
from biophysical techniques foreign to most bio-
chemists. In order to appreciate current investiga-
tions on the roles of surfactant lipids, it is imperative
to understand the kind of information derived from
these techniques and, just as importantly, their limi-
tations. The reader can ¢nd further information in
previous reviews [19^21].
The Langmuir-Wilhelmy surface balance, designed
by Clements for his initial studies [5,22], consists of a
trough whose surface area can be varied, and a Wil-
helmy dipping plate which monitors surface tension
[19,20]. This apparatus is well suited for examining
area-surface tension characteristics with dilute ¢lms,
that is, surfactant ¢lms with surface tensions between
the 70 mN/m observed with a clean saline surface at
37‡C and the equilibrium surface tension of approx.
25 mN/m for phospholipids. The equilibrium surface
tension is the lowest surface tension pure or mixed
phospholipid ¢lms can achieve, given su⁄cient lipids
and a long enough time. Identical equilibrium sur-
face tensions are observed whether the phospholipid
is spread from above or adsorbed from below. Sur-
factant apoproteins increase adsorption rate, but to
the same equilibrium surface tension.
Lateral compression of insoluble ¢lms decreases
the surface area such that surface tension can fall
below equilibrium. Such ¢lms are inherently unstable
by de¢nition and therefore in a metastable state. The
high surface pressure required to attain low surface
tensions can result in loss of ¢lm material, not only
by ¢lm collapse but also onto or under the te£on
barriers. This loss, termed ‘leakage’, is dependent
on the sample and is more serious with increased
levels of £uid lipids, i.e., lipids above their corre-
sponding gel-to-liquid transition temperatures for bi-
layers, and for surfactants with neutral lipids. Such
¢lms cannot pack in an ordered fashion and are less
stable than ¢lms of phospholipids below their corre-
sponding bilayer gel-to-liquid crystalline transition
temperatures. The Langmuir-Wilhelmy balance is
particularly suited for studying spread ¢lms. At
present, it is the only technique where precise
amounts of ¢lm material can be deposited, where
surface radioactivity can be monitored conveniently,
and where £uorescent probes can be used to study
¢lm structure.
The pulsating bubble surfactometer introduced by
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Enhorning in 1977 [23] consists of an air bubble con-
nected by a capillary to the atmosphere. With this
arti¢cial alveolus model, a bubble created within a
suspension of the surfactant sample is pulsated, nor-
mally at 20 cycles/min at 37‡C, and the pressure
across the bubble monitored [19]. The law of Young
and Laplace, which states that the pressure across
the bubble equals twice the surface tension divided
by the radius, is used to calculate surface tension.
The pulsating bubble monitors adsorption of surfac-
tant during bubble expansion and its ability to ob-
tain low surface tension during ¢lm compression gen-
erated during the 50% surface area change which
occurs during reduction of bubble volume. The sur-
face tension at maximum bubble radius is indicative
of surfactant adsorption during surface expansion,
while the surface at minimum radius indicates the
¢lm’s ability to achieve low surface tensions during
compression. These parameters are important deter-
minants of the quality of the surfactant and, in gen-
eral, re£ect the biological activity of the surfactant in
vivo. The small amounts of sample required, the rel-
atively short time needed, and the relatively straight-
forward technical requirements recommend this
assay. It functions best at relatively high concentra-
tions (1^10 mg/ml) and short pulsation periods be-
cause with the time bubble radius can change during
pulsation. However, at low surface tensions (i.e.,
high surface pressures), surface material can be
pushed onto the capillary so the true surface area
reduction is less than 50%. Initiating pulsation while
the capillary walls are wetted can also lead to in-
creased surface area [24]. The pulsating bubble is
extremely useful for monitoring the quality of surfac-
tant relative to its biological activity, but can be
problematic for mechanistic studies.
The last technique to be discussed here, the captive
bubble tensiometer introduced by Schu«rch [25], con-
sists of a gas-tight chamber containing a bubble
£oating against a hydrophilic agar gel. Increasing
the pressure within the chamber compresses the bub-
ble, thereby decreasing surface area. The hydrophilic
agar roof is incapable of accepting hydrophobic lip-
ids, resulting in an apparently leak-proof system. The
captive bubble tensiometer is more accurate but is
very time-consuming compared to the pulsating bub-
ble surfactometer, both experimentally and for data
analysis. However, this apparatus is extremely £exi-
ble in terms of controlling surface area reduction,
speed of compression, and manipulation of other
bubble characteristics. One example of new informa-
tion obtained with this apparatus is evidence for a
surface-associated surfactant reservoir which selec-
tively replenishes the surface ¢lm with DPPC-rich
material during surface area expansion (see below).
3.2. Reconstitution studies and in vivo alterations in
surfactant composition
In general, knowledge regarding the role of lipids
in surfactant function arises from two approaches:
reconstitution studies where puri¢ed or synthetic lip-
id and protein components are combined, and stud-
ies where physiological conditions occur or are im-
posed which result in alteration of the surfactant
system in vivo. Surfactant reconstitution studies can
employ simple mixtures, providing insight into the
contributions made by individual components under
speci¢c conditions. Physiological conditions leading
to surfactant alteration include not only acute lung
injury but also transplantation after prolonged stor-
age, mechanical ventilation, and physiological states
such as exercise. As will be discussed later, with some
non-mammalian species, temperature adaptation re-
sults in signi¢cant alterations in overall surfactant
composition.
With acute lung injury and a number of other
conditions small decreases in DPPC as a proportion
of PC and increases in the PI/PG ratio are often
observed. Increases in the level of so-called ‘mem-
brane phospholipids’, PE, PS and sphingomyelin
(SM) have also been noted. In some cases, lyso-PC,
a product of phospholipase A2 degradation, can also
increase. Alterations arising during severe lung injury
are remarkably consistent among various species and
di¡erent initiating causes [26,27]. These alterations in
phospholipid composition are not only indicative of
lung injury, but could contribute to surfactant dys-
function within the lung. It must be pointed out that
studies in which organic solvent lipid extracts were
altered by addition of speci¢c lipids produced no
detectable e¡ects on pulsating bubble surfactometer
tracings (I.L. Metcalfe, F. Possmayer, unpublished
results; A.M. Cockshutt, F. Possmayer, unpublished
results). However, surfactant isolation unavoidably
results in an averaging of total lung surfactant com-
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position. Even with uniform forms of acute lung in-
jury, considerable variation is likely. Marked altera-
tions in surfactant lipid composition in individual
alveoli could lead to localized surfactant dysfunction
without greatly a¡ecting overall composition. In ad-
dition, to the best of our knowledge, the e¡ect of
combined alterations in surfactant lipids has not
been examined.
Lung injuries are often, if not universally, accom-
panied by increases in alveolar serum protein con-
tent. Increases in lyso-PC level which did not in£u-
ence the surface activity of bovine lipid extract
surfactants on the pulsating bubble surfactometer
sensitized this preparation to inhibition by serum
proteins. Furthermore, SP-A, which prevents protein
inhibition, did not reverse inhibition arising from
lyso-PC [28].
It should also be recognized that interpretation of
results relating alterations in surfactant lipids to sur-
factant function in vivo is complicated by the fact
that lung injury-associated surfactant alterations do
not occur in isolation. The acute lung injury changes
in lipid pro¢le are invariably accompanied by alter-
ations in surfactant apoprotein content, and as indi-
cated above, increases in serum proteins, which can
inhibit surfactant.
4. The roles of speci¢c lipids in surfactant function
Surfactant is a complex mixture of proteins and
lipids. In the lung this complex functions to reduce
the surface tension at the air-liquid interface. For
some of the major lipid classes a role in this process
has been indicated, but for most of the minor lipid
components their exact contribution must still be es-
tablished. It should also be noted that whereas most
of the experimental focus has been on surface ten-
sion-reducing properties of surfactant, the lipid com-
ponents of surfactant could also be involved in other
metabolic aspects of the surfactant life cycle, for ex-
ample lamellar body assembly and secretion. These
areas require further study.
4.1. Phosphatidylcholines
The need for low surface tensions approaching
0 mN/m to stabilize the lungs during expiration
was ¢rst suggested by Clements in 1957, based on
theoretical calculations [5]. DPPC is not only the
major component of pulmonary surfactant, but
also the only major component capable of generating
low surface tensions during compression on the
Langmuir-Wilhelmy balance and the captive bubble
tensiometer. With the captive bubble tensiometer,
area reductions of 10^12% are su⁄cient to lower sur-
face tension of pure DPPC ¢lms from equilibrium
(approx. 25 mN/m) to less than 2 mN/m. Further-
more, if surface area is held constant, the ¢lm main-
tains a low surface tension and returns towards equi-
librium only after many hours. In situ studies by
Schu«rch, which used the lung as a surface balance
by employing £uorocarbon microdroplets to assess
alveolar surface tension, have revealed surface ten-
sions of 30 mN/m, slightly above equilibrium at total
lung capacity (TLC) [29]. Reducing lung volume to
functional residual capacity (FRC) is accompanied
by a 20% reduction in surface area and a fall in
surface tension to near 1 mN/m. When held at
FRC, surface tension remains low for several mi-
nutes, showing the alveolar surface ¢lm is stable.
The properties of DPPC mentioned above contrast
with those of unsaturated PC ¢lms above the gel-to-
liquid crystalline transition temperature of bilayers
composed of the same lipids. Since such £uid ¢lms
cannot pack in an ordered fashion, compression
can lower surface tension only to 15^20 mN/m, and
when dynamic compression ceases, surface tension
returns towards equilibrium. Such surface tensions
are incapable of stabilizing the lung at low lung vol-
umes [29^31]. Thus it is implied that the lung con-
tains a ¢lm highly enriched in DPPC. As indicated
earlier, the alveolar surface monolayer cannot be
sampled, so chemical evidence for a DPPC ¢lm is
lacking.
Vesicles of pure DPPC, below the phase transition
temperature of 41‡C, form a surface monolayer only
extremely slowly and therefore are incapable of act-
ing directly as an adequate surfactant replacement.
Addition of unsaturated PCs (or other £uid phos-
pholipid or neutral lipid components) enhances ad-
sorption [19] (see chapters by Goerke and Pe¤rez-Gil
and Keough). However, in the absence of the low
molecular weight hydrophobic proteins or some oth-
er adsorbance-inducing factor, adsorption of such
mixtures is still inadequate. Nevertheless, it is
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thought the £uidity resulting from unsaturated phos-
pholipids and other £uid components is important
for enhancing adsorption to a clean surface. Further-
more, SP-B and SP-C are very e¡ective in promoting
adsorption of surfactant lipids to partially ¢lled
monolayers so that equilibrium surface tension is
rapidly attained [32].
Studies with the captive bubble tensiometer sug-
gest two mechanisms, selective DPPC adsorption
and preferential squeeze-out of unsaturated lipids,
could be involved in DPPC enrichment of the inter-
facial ¢lm [19] (see chapters by Schu«rch and by
Pe¤rez-Gil and Keough). For example, bovine lipid
extract surfactant (BLES) lipids are approx. 40%
disaturated (Table 1). However, in the captive bub-
ble, BLES ¢lms adsorbed to the equilibrium value of
25 mN/m, require only 30^35% surface area reduc-
tion to change surface tensions to near 0 mN/m.
When SP-A is added, surface area reductions of
20^25% are su⁄cient. Perfect squeeze-out of the
less stable unsaturated lipid components of BLES
(40% disaturated) would require 60% surface area
reduction. A further 4^5% surface area reduction
would be required to pack the remaining DPPC to
reduce surface tension from equilibrium to near 0.
This indicates the initial adsorbed ¢lm is highly en-
riched in DPPC. With additional compression-de-
compression cycles, surface area reduction required
to achieve low surface tension declines further to 15^
20%, a value consistent with a remaining ¢lm even
more highly enriched in DPPC.
The £uid components of pulmonary surfactant,
such as PC and the other lipids, could also play an
important role in ¢lm respreading. DPPC ¢lms can
be repeatedly cycled between equilibrium and 1 mN/
m. Such cycling occurs reversibly without hysteresis
[29] (hysteresis implies non-reversible behaviour).
Nor is hysteresis observed with the lung during quiet
tidal breathing. However, overcompression of DPPC
¢lms at low surface tension results not only in hys-
teresis, but leads to ever-increasing surface tensions
during subsequent cycles. This occurs because DPPC
forced out of the monolayer into a collapsed state
cannot reform the monolayer rapidly (i.e., cannot
respread). As suggested above, the £uid components
of pulmonary surfactant and the surfactant apopro-
teins could be important for respreading. As dis-
cussed further by Schu«rch et al. (pp. 180^202, this
issue), washout experiments with the captive bubble
tensiometer have provided evidence for a surface-as-
sociated surfactant reservoir, which appears to be
important for feeding DPPC-enriched material into
the surface monolayer during ¢lm expansion. Re-
plenishing the surface monolayer with DPPC-en-
riched components is particularly important after
¢lm overcompression. This reservoir is dependent
on the palmitoylated SP-C [33^35].
Although considered less often, the £uid compo-
nents of pulmonary surfactant could be important in
other aspects of the surfactant cycle. The processing
and packaging of pure DPPC into lamellar bodies
could present di⁄culties arising from the sti¡ness
of this phospholipid. The e¡ect of lipid £uidity could
be important for secretion of lamellar bodies, forma-
tion of tubular myelin and/or other precursors of the
surface ¢lm, and in the re-uptake of surfactant com-
ponents by the type II cells [36]. It should be evident
that the ancillary functions suggested for unsaturated
PC, discussed here, will apply to unsaturated PG and
the other £uidizing phospholipids and neutral lipid
components of pulmonary surfactant.
In summary, it appears likely that the surface ¢lm
covering the alveoli is highly enriched in DPPC. Un-
saturated PC and other £uid components could facil-
itate adsorption of surfactant lipids but such a role
has not been proven.
4.2. Acidic phospholipids
The observation that all pulmonary surfactants
possess signi¢cant amounts of PG and/or PI suggests
an important speci¢c role. Mixing £uid acidic phos-
pholipids with DPPC leads to enhanced adsorption,
suggesting a potential role in surface tension reduc-
tion [37]. A speci¢c interaction between PG and SP-B
has been suggested by £uorescence studies [38] and
by the highly surface-active properties observed with
DPPC-PG-SP-B mixtures [39]. As suggested above,
DPPC-enriched ¢lms could arise through the prefer-
ential adsorption of DPPC during ¢lm formation,
through selective PG squeeze-out during compres-
sion, or both. With DPPC-PG mixtures, SP-B ap-
pears superior to SP-C both in promoting preferen-
tial DPPC adsorption and facilitating PG squeeze-
out [34,39]. Such selective squeeze-out is not ob-
served during compression of either spread or ad-
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sorbed phospholipid ¢lms in the absence of SP-B or
SP-C [40].
Decreases in the amount of PG have been ob-
served in patients with ARDS and in other acute
disease states. As with the decrease in DPPC, it has
been suggested the lower PG levels could be involved
in the decreased biophysical activity of recovered ma-
terial. It has also been inferred that the high PI/PG
ratios noted with surfactant from premature animals
could result in lower activity. However, recent stud-
ies have suggested di¡erences in SP-A could account
for the lower in vitro and in vivo activity of pulmo-
nary surfactant recovered from lambs of di¡erent
gestational ages [41] (see chapter by Jobe for further
discussion). Increasing the proportion of PI in sur-
factant by administering inositol to adult rabbits had
no signi¢cant e¡ect on surfactant function in vitro or
in vivo [42,43].
In summary, acidic phospholipids represent a sig-
ni¢cant component of pulmonary surfactant. How-
ever, their precise role and why PG rather than PI is
present in most adult surfactants are not understood
and require further study.
4.3. Minor phospholipid components
Analysis of surfactant has revealed the consistent
presence of a number of phospholipids present in
relatively low amounts (Table 1). In general the
role of these lipids is not clear and investigations
into their contribution to surfactant function have
been limited. From a surface tension reduction per-
spective it would be anticipated that these low
amounts of phospholipids would have minimal ef-
fects on surfactant activity. The higher amounts of
these lipids observed in lung injury could contribute
to decreased surfactant activity, but there is no spe-
ci¢c evidence for this. The exception is lyso-PC,
which can make surfactants more susceptible to pro-
tein inhibition [28].
Since a speci¢c surface active role for these minor
lipid components of surfactant appears unlikely, oth-
er explanations for their presence in surfactant have
to be sought. The presence of some of these lipids in
surfactant could be related to some metabolic as-
pects. For example, small amounts of an acidic phos-
pholipid thought to be lyso-bis-phosphatidic acid is
present in most surfactants (Table 1), although the
precise nature of this lipid has not been determined.
Lysosomes contain lyso-bis-phosphatidic acid and
since lamellar bodies are thought to be modi¢ed ly-
sosomes, the presence of lyso-bis-phosphatidic acid
in surfactant could be related to this origin. It could
be that the lamellar body limiting membrane con-
tains higher levels of the membrane lipids PE and
SM. The limiting membrane does contain high levels
of cholesterol (S. Orgeig, T.E. Nichols, unpublished
results). The limiting membrane fuses with the plas-
ma membrane during exocytosis, but some limiting
membrane may be ejected with surfactant. It should
also be recognized that the minor phospholipid com-
ponents could be involved in signalling events related
to surfactant metabolism. However, this has not been
demonstrated.
4.4. Neutral lipids
Although present in signi¢cant amounts, the neu-
tral lipids of surfactant have received far less atten-
tion experimentally than the phospholipids. Neutral
lipid e¡ects are complex and depend on the system
being studied and the technique used for investiga-
tion. Addition of mono-, di-, and triacylglycerol or
free palmitic acid to DPPC or DPPC-PG enhance
adsorption rate, presumably by introducing minor
packing defects in the membrane structure. Choles-
terol can also enhance adsorption of vesicles primar-
ily composed of DPPC, presumably by increasing
£uidity, and improve ¢lm respreading [44,45]. How-
ever, it should be noted that, by increasing £uidity,
cholesterol limits the minimum surface tensions ob-
tainable during compression. This occurs because
this sterol cannot be squeezed out easily from
DPPC-cholesterol spread ¢lms [44,46,47]. Possibly
for this reason, cholesterol is removed from most
modi¢ed natural surfactants used clinically for treat-
ing neonates. Whether removing cholesterol a¡ects
physiological function signi¢cantly has not been es-
tablished.
The e¡ect of neutral lipids on the surface activity
of DPPC and DPPC-PG has been examined using
reconstitution studies by Tanaka et al. [48]. These
investigators found the most e¡ective reconstituted
preparation contained DPPC, PG, tripalmitate or
palmitic acid, and the hydrophobic surfactant pro-
teins. DPPC-hydrophobic apoproteins and DPPC-
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PG-hydrophobic apoprotein mixtures adsorbed well
but were not e¡ective in attaining low surface ten-
sions during surface area reduction on the Langmuir-
Wilhelmy balance. Surface activity was markedly im-
proved by addition of high amounts of neutral lipids
(tripalmitin and/or palmitic acid). Mixtures contain-
ing DPPC-PG-palmitic acid and hydrophobic apo-
proteins were also e¡ective in promoting lung expan-
sion in prematurely delivered rabbit pups of 27 days
gestation.
Removing cholesterol from bovine surfactant lipid
extracts hampers adsorption activity at 25‡C but not
37‡C. Interestingly, SP-A greatly retarded the ability
of radioactive cholesterol in [14C]cholesterol-labelled
BLES to attain the air-liquid interface during ad-
sorption to equilibrium [46]. Furthermore, the addi-
tion of SP-A markedly enhanced the surface activity
of such preparations during compression on the
Langmuir-Wilhelmy surface balance and during pul-
sation with the pulsating bubble surfactometer.
These results are consistent with SP-A enhancing
DPPC adsorption while limiting cholesterol access
to the air-liquid interface. SP-A also appears to
bind pure cholesterol ¢lms in such a manner as to
increase their surface activity during compression
[47]. The exact manner in which SP-A in£uences sur-
face activity of the phospholipid-cholesterol mixtures
in BLES is not known, but could be related to the
formation of surface-associated phospholipid aggre-
gates rich in DPPC [46,47].
In contrast to studies conducted with the Lang-
muir-Wilhelmy surface balance and the pulsating
bubble surfactometer, cholesterol appears to have
minimal e¡ects on surface tension reduction of
BLES with the captive bubble tensiometer [49].
Thus, some of the detrimental e¡ects attributed to
cholesterol in lipid extract surfactants may be related
to ¢lm leakage associated with the particular appa-
ratus being used.
An intriguing, and as yet unexplained, aspect of
surfactant lipid composition is the fact that di¡erent
species possess quite di¡erent proportions of neutral
lipids relative to phospholipids. Interestingly, choles-
terol levels in lung surfactant can vary rapidly. For
example, the hyperventilation induced in swimming
rats lowers the cholesterol/disaturated PC ratio.
Studies with the isolated perfused lung model indi-
cate there may be an alternate (i.e., non-lamellar
body) source of cholesterol which is rapidly mobi-
lized by hyperventilation [50]. In addition, trained
athletes demonstrated a decrease in cholesterol/disa-
turated PC ratio during intense activity compared
with less ¢t individuals who demonstrated an in-
crease in this ratio [51]. The signi¢cance of these
rapid alterations in surfactant sterol levels is not
known.
As indicated above, the other neutral lipids have
not been extensively examined. Surfactant possesses
small amounts of vitamin E which could function as
an internal anti-oxidant. There is also a very small
amount of plasmalogen in lung which could also
function in this capacity [52].
5. Recent contributions from novel approaches
Recent technical advances hold great potential for
improving our understanding of what surfactant is
and how it functions. For example, the electron
spray mass spectrometer tracing of BLES lipids de-
picted in Fig. 1, which shows individual lipid molec-
ular species, allows for exceptional sensitivity and
accuracy. Mass spectrometer analysis using matrix-
assisted methodology has been applied to SP-B and
SP-C [53]. The advent of novel microscopic and spec-
troscopic techniques capable of detecting individual
lipid-lipid and lipid-protein molecular interactions
and associations could provide direct means for an-
swering fundamental questions not accessible by con-
ventional surface chemistry (i.e., do minor lipid com-
ponents play speci¢c roles in forming and
maintaining the interfacial layer? Do surfactant pro-
teins attain and remain at the surface?).
During the past decade, £uorescent microscopic
techniques have provided direct visual con¢rmation
of earlier suggestions by Clements and others (see
chapter by Goerke) that DPPC ¢lms undergo phase
transitions during dynamic compression at the air-
water interface. As ¢lms containing DPPC are com-
pressed, the lipids assemble into gel-like condensed
phases, and then with further packing, into a solid-
like phase. Each phase transition is re£ected by the
appearance of a transitory aggregated lipid structure
in one phase coexisting with another. A solid-like
phase generated below 20 mN/m may represent
structures capable of withstanding high surface pres-
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sures, so as to generate low surface tensions near
0 mN/m. Condensed structures generated within
DPPC ¢lms possess peculiar, yet characteristic, kid-
ney-shaped structures (Fig. 2A,B) [54]. Such struc-
tures have recently been observed with surfactant
extract preparations [55,56]. These structures are
not £uorescent probe-induced artifacts, since they
can also be observed at the air-water interface by
non-probe-dependent techniques such as Brewster
angle microscopy [55]. Similar structures are ob-
served with solvent or vesicle-spread and also with
adsorbed ¢lms [57].
It should be apparent that surface-£uorescence
studies can provide unique structural detail not ac-
cessible by conventional surface techniques. As sug-
gested by Pierre Giles DeGennes, Nobel Laureate in
1991 for studies on ‘Soft Matter’ [58], the DPPC
condensed regions can be considered as a form of a
liquid-crystalline structure. Such structures are
formed due to di¡erential tilt and orientation of in-
dividual molecules in the ¢lms during packing. These
monomolecular model ¢lms can also be used to
study the manner in which other lipids present in
surfactant interact with DPPC-condensed structures
at the interface. Small amounts of cholesterol change
the DPPC-condensed structures from kidney shapes
to elaborate ¢ne structures (Fig. 2C^F). When added
together with PG, the kidney-shaped structures are
modi¢ed to appear stellate (Fig. 2G). When calcium
is also present, there is increased DPPC condensa-
Fig. 1. A typical mass spectrum of phospholipid species present in BLES. The mass spectrum was obtained using electrospray ioniza-
tion mass spectrometry of organic solutions of BLES. The lipid species identi¢ed as their exact molecular mass and chain distributions
are shown in parentheses. DPPC, dipalmitoylphosphatidylcholine; POPC, 1-palmitoyl, 2 oleyl-PC.
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Fig. 2. Various phase structures formed in DPPC and mixed lipid ¢lms as observed using £uorescence microscopy at an air-saline in-
terface at 60 mN/m and 25‡C. The structures arise due to lipid-lipid interactions, and multiple tilt and orientation of the molecules
perpendicular to the plane of the air-water interface. The structures were observed in ¢lms of DPPC (A,B); DPPC with cholesterol
(0.2^4 mol%) (C^F); at surface pressures near the gel-£uid phase coexistence regions of such ¢lms (3^14 mN/m). Images G and H in-
dicate DPPC ¢lms containing PG (DPPC-DPPG), 7:3) and unsaturated POPC and cholesterol (DPPC-POPC-cholesterol, 7:2:1) re-
spectively. The black regions indicate the gel-like liquid-condensed (LC) phase and the white the £uid liquid expanded (LE) phase.
The LC phases are observed by £uorescence microscopy from the exclusion of £uorescent probes from such regions. Note the high
susceptibility of the molecular packing or shape of the gel domains of DPPC in ¢lms to minor amounts of perturbants like cholester-
ol. The £uorescent probe was 1-palmitoyl, 2-nitrobenzoxadiole amino-dodecanoyl (NBD)-phosphatidylcholine. Scale bar is 25 Wm.
(From [54].)
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tion, resulting in formation of multi-sized, circular
domains (Fig. 2F). Recent studies with £uorescent-
labelled ¢lms have con¢rmed the ability of unsatu-
rated PC to promote DPPC respreading from con-
densed structures, providing further evidence for the
reversible squeeze-out of PC and, in the presence of
calcium, of PG during ¢lm compression [56]. Studies
with £uorescent-labelled cholesterol have con¢rmed
this steroid cannot be readily squeezed out of DPPC
¢lms [44,47,59].
The £uorescence approach also provides direct evi-
dence for surfactant apoprotein interaction with lip-
ids in surfactant ¢lms. SP-C alters DPPC and DPPC-
PG packing in solvent-spread and adsorbed ¢lms
[35,53,57]. The presence of multilayered structures
resulting from molecular squeeze-out in the presence
of SP-C has been directly demonstrated by atomic
force microscopic analysis of ¢lms compressed to
low surface tensions [35]. Such structures are consis-
tent with the role of SP-C acylation in the generation
of a surface-associated surfactant reservoir [34]. SP-B
and SP-B-like peptides interact with DPPC-DPPG
¢lms di¡erently from SP-C in that they form protein
networks at the surface. Such protein networks could
provide initiation sites for molecular squeeze-out
[60], thus explaining the remarkable ability of SP-B
to promote PG squeeze-out [61].
The propensity of SP-A to bind to gel-like con-
densed regions of DPPC has been directly demon-
strated by £uorescence techniques [62]. SP-A:DPPC
interactions are highly sensitive to ionic conditions.
That calcium and other ions a¡ect SP-A-DPPC in-
teractions has also been shown with transmission
electron microscopy. The latter electron microscopic
investigations reveal that SP-A interacts with DPPC
via its C-terminal carbohydrate recognition domains
[63], as has been inferred from site-directed mutagen-
esis of SP-A [64]. The £uorescence microscopic inves-
tigations indicate that small amounts of surfactant
apoproteins remain associated with surfactant ¢lms
compressed to near zero, suggesting the proteins
could be involved in respreading [53,62] as previously
indicated by captive bubble tensiometric studies
[33,34]. Readers are referred to chapters by Pe¤rez-
Gil and Keough and by Schu«rch in this dedicated
issue for further details on these aspects.
As indicated above, condensed domains reminis-
cent of those observed with DPPC ¢lms can be ob-
Fig. 3. Fluorescence micrographs of ¢lms of porcine lipid sur-
factant extract, at high (50 mN/m) (A), intermediate (30 mN/m)
(B) and low (10 mN/m) (C) surface tensions. The dark con-
densed domains seen in B are probably composed primarily of
DPPC, as their total area estimates agree well with the propor-
tion of DPPC present in porcine surfactant [54,55]. The bright
structures with black spots (in C) appear to be multilayered
squeezed-out materials from such ¢lms above the air-water in-
terface. The £uorescent probe was 1-palmitoyl, 2-nitrobenzoxa-
diazole aminododecanoyl (NBD)-phosphatidylcholine.
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served during lateral packing of porcine lipid extract
surfactant (Fig. 3) [54]. The presence of subphase
calcium produces a further increase in condensed
phase area, suggesting the possibility that PG, com-
plexed with calcium, may coexist within the DPPC-
rich regions [56]. Further addition of SP-A to such
systems results in coalescence of separate DPPC-like
domains, resulting in a smaller number of larger con-
densed regions, but with a similar overall surface
area. Although the actual molecular composition of
these aggregated domains is unknown, it is clear they
are DPPC-rich. When cholesterol is also present, cal-
cium induces formation of novel, still not-understood
multilayer structures at surface tensions near 0 mN/
m (Fig. 3C). Whether such structures are related to
the surface-associated reservoir [33] or to DPPC-rich
cholesterol-poor surface ¢lm-associated aggregates
arising during ¢lm formation [46,47] is not known.
However, it appears these structures could be capa-
ble of ¢lm replenishment during surface area expan-
sion [55,56]. Recent investigations using X-ray dif-
fraction to examine DPPC ¢lms at low surface
tensions indicate the presence of head group dehy-
dration, which could further stabilize monolayers at
low surface tensions and enhance interactions with
hydrophobic areas of SP-B and with calcium [53,56].
6. Non-mammalian surfactants
The pulmonary surfactant system, including both
the lipids and SP-A, is present in the lungs of air-
breathing representatives of all vertebrate groups
[65,66]. In fact, it appears surfactant function related
to air breathing evolved at least 400 million years
ago in the lungs of primitive air-breathing ¢sh and
has been highly conserved [66]. This suggests surfac-
tant could have ‘older’ and perhaps some as yet un-
de¢ned functions. Furthermore, relatively large
amounts of surfactant have also been found in the
swim bladders of modern teleost ¢sh such as the
gold¢sh [67]. The role of surfactant in the swim blad-
Table 2
Phospholipid pro¢les for lavage material for di¡erent species
Phospholipid composition (% total) [% disaturated] Cholesterol (% chol/PL)
PC LPC SM PS/PI PE PG
C. auratusa 75 0 15.9 5.1 4.7 1.2 32.8
Gold¢sh [27.7]
L. osseusb 76.4 3 5.9 7.9 4.6 1.4 17.5
Gar ¢sh [18.5]
N. forsteric 59.6 0 15.3 10.2 14.4 0.5 24.2
Australian lung¢sh [9.0]
P. annectensc 80.2 0.4 5.6 7.9 3 3 5.2
African lung¢sh [25.4]
B. marinusb 62.6 6.1 8.6 9 13.1 13
Cane toad [5.6]
N. depressusd 70.7 0 9.9 19.4 0 0 6.1
Sea turtle [39.5]
C. porosusd 67.6 0 4.7 25 2.5 0 6.7
Crocodile [50.0]
C. atroxb 68.6 17.7 11.7 1.4 0 0 7.9
Rattlesnake [63.6]
C. nuchalisb 73.8 0 2.5 23.7 0 0 8
Lizard [62.8]
S. crassicaudatae 70.7 0 7.7 13.5 2.1 6 6.4
Dunnart [56.9]
Amounts of phospholipids are given as the percentage of total phospholipids. PC, phosphatidylcholine; LPC, lysophosphatidylcholine;
SM, sphingomyelin; PS, phosphatidylserine; PI, phosphatidylinositol ; PE, phosphatidylethanolamine; PG, phosphatidylglycerol ; chol,
cholesterol ; PL, phospholipid.
Data from: aDaniels and Skinner, 1994 [67]; bDaniels et al., 1995 [65]; cOrgeig and Daniels, 1995 [79]; dDaniels et al., 1996 [80];
eLangman et al., 1996 [71]. All samples collected at room temperature except sea turtles (32‡C) and lizards (37‡C).
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der, which is derived from the lungs of air-breathing
¢sh, is not completely known. However, as the swim
bladder is not required for air breathing, this ¢nding
suggests that surfactant is requisite for an in£ating/
de£ating organ with an air-liquid interface.
Early work on mammalian pulmonary surfactant
focussed on lipid components, in particular DPPC.
The relative lack of this so-called ‘active ingredient’
in the lungs of non-mammalian vertebrates led to the
concept that these surfactants were less important for
airway stabilization and may function as an anti-ad-
herent (also known as an ‘anti-glue’) factor and as an
anti-oedemic factor, rather than as an anti-atelectatic
agent. Studies on non-mammalian surfactants not
only provide interesting insights into the evolution-
ary aspects of pulmonary surfactant, but similarities
and di¡erences between these surfactants could prove
valuable in identifying new roles for speci¢c compo-
nents. Furthermore, non-mammalian species have
provided valuable model systems for studying surfac-
tant and its functions under di¡erent physiological
conditions, such as alterations in body temperature.
Table 2 presents the phospholipid composition of
a number of non-mammalian surfactants. While not
identical, there are obvious similarities to each other
and to mammalian surfactants. Interesting di¡eren-
ces are the higher levels of SM in many species and
the extremely high levels of lyso-PC in snakes. Most
of the PS/PI appears to be PI but PG tends to be low
or absent. The exception appears to be the anurans
(frogs and toads), which demonstrate a similar PG/
PI pattern to mammals. This may be an example of
convergent evolution. Depending on the species, PE
can be higher or lower than with mammals.
The major di¡erences between surfactants from
mammalian and non-mammalian species are the pro-
portion of disaturated PC and the amount of neutral
lipids. Compositional di¡erences also occur between
di¡erent non-mammalian species. Among the latter
species, the disaturated PC varies from approx. 10 to
30% in ¢sh and amphibians, and up to 60% in rep-
tiles. (Note that the disaturated PC levels in Table 2
were determined with the osmium tetroxide techni-
que of Mason [15], which gives higher values than
the molecular species methods used for the values in
Table 1. For example, the Mason method indicates
PC from human surfactant is 67.3% disaturated com-
pared to the 44.7% reported by the more accurate
molecular species method. Thus, the values for disa-
turated PC in Table 2 could be elevated by approx.
20% relative to Table 1.) Nevertheless, it is clear
there is a signi¢cant e¡ect of body temperature which
a¡ects disaturated phospholipid as a percentage of
total in di¡erent species. The compositional variation
among groups may re£ect a balance between temper-
ature-dependent £uidity of surfactant phospholipids
due to the need to maintain homeoviscosity (similar
viscosity at di¡erent temperatures) and the requisite
low surface tensions during expiration. Only homeo-
therms and some heliothermic reptiles experience
body temperatures which approach the 41‡C gel-to-
liquid crystalline transition temperatures of DPPC
bilayers. It is generally thought that only these ani-
mals require (or can tolerate) high disaturated PC
levels. However, lipid extracts of mammalian surfac-
tant with high disaturated PC levels display £uid
characteristics at 20^25‡C and show similar surface
activities at 25‡ and 37‡C on the pulsating bubble
surfactometer [61,68]. This suggests the possibility
that simply being in the £uid state at body temper-
atures may not be su⁄cient to meet the demands on
the surfactant system in poikilotherms. Unfortu-
nately, the nature of these demands, which impose
relatively low disaturation levels, must still be de-
¢ned.
A major di¡erence between species in Tables 1 and
2 is the cholesterol content. In mammals, cholesterol
relative to phospholipid varies from approx. 3% in
the cow to approx. 10% in the rat and sheep. A
similar 3^10% range is observed for most non-mam-
malian species, but this can be greater in speci¢c
species. Surfactant from gold¢sh swim bladders and
the lungs of ancient air-breathing ¢sh (actinoptery-
gians) have high cholesterol (15^35%), as does the
primitive Australian lung¢sh (N. forsteri). These
¢sh also have relatively low (10^30%) disaturated
PC levels. These values contrast with the high disa-
turated phospholipid and relatively low cholesterol
values in rat and human surfactant (Table 1) and
snake and lizard surfactant (Table 2). However, the
African and South American lung¢sh have inter-
mediate (25^38%) disaturated lipids and low (5%)
cholesterol levels. Intermediate PC disaturation and
low cholesterol levels are also observed with sala-
manders, turtles and toads. A possible explanation
for the radically di¡erent lipid pro¢les of surfactant
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from the teleost ¢sh, primitive air-breathing ¢sh, and
Australian lung¢sh (high cholesterol and low disatu-
rated PC) is that it may represent a proto-surfactant
which is used infrequently in air breathing, but is
important for other functions in the swim bladder.
Apart from the evolutionary trends in surfactant
composition between vertebrate groups, there are
also di¡erences within a particular group such as
the amphibians. For example, temperature can a¡ect
surfactant composition via habitat preference, be-
cause terrestrial amphibians as a group have a sur-
factant lipid pro¢le which is di¡erent from aquatic
amphibians. Terrestrial amphibians with variable
body temperatures possess surfactants low in both
disaturated PC (13^20%) and cholesterol (0^6%),
while aquatic amphibians with more stable body
temperatures have high disaturated PC (26^43%)
and cholesterol (8^11%) [69]. With both groups, rel-
atively similar cholesterol to disaturated PC ratios
are observed, implying the proportion of cholesterol
to disaturated PC must be kept within certain limits.
Temperature also has profound e¡ects on the re-
lation between cholesterol and disaturated lipids
within individual species. For example, decreasing
the body temperature of the lizard, Ctenophorus nu-
chalis, from 37‡C to 18‡C results in a doubling of
surfactant cholesterol [70]. Similarly a torpid marsu-
pial, the fat-tailed dunnart (Sminthopsis crassicauda-
ta), exhibits a higher ratio of cholesterol to total and
disaturated phospholipid (11% and 22% respectively)
at 15‡C than at its normal active body temperature
of 35‡C (7% and 18%) [71] (marsupials are a subclass
of mammals but it was thought appropriate to men-
tion this study with non-mammalian species). These
changes occur within a few hours, showing an amaz-
ing ability of the surfactant system to adapt in these
animals. A possible explanation is that cholesterol
functions to modulate the £uidity of the surfactant
lipids, thereby enhancing surfactant adsorption, par-
ticularly at low temperatures. Certainly in the dun-
nart the alteration in surfactant lipid composition
during torpor (a form of diurnal hibernation) corre-
lates with surfactant activity. For example, surfac-
tant from torpid dunnarts is more e¡ective in low-
ering surface tension during compression at 20‡C
than 37‡C. Moreover, surfactant from torpid dun-
narts has a reduced ability to lower surface tension
during compression at 37‡C when compared to sur-
factant from warm-active dunnarts measured. Hence,
it appears that this species is capable of altering its
surfactant composition in response to £uctuations in
body temperature, thereby optimizing its surface ten-
sion modulating ability [72].
Since surfactant recovered from non-mammalian
vertebrates is generally less disaturated, the surface
activity tends to be relatively low. Fish, amphibian,
bird, and some reptiles have surfactants which ap-
pear incapable of attaining low surface tensions dur-
ing surface area reduction on the Langmuir-Wil-
helmy balance, which has normally been used for
these studies [73]. Only a few heliothermic lizards
with very high preferred body temperatures (e.g.,
Pogona vitticeps and Trachydosaurus rugosa) and
mammals possess surfactant which demonstrates
high surface activity. Non-mammals (other than
birds) possess relatively large, highly compliant res-
piratory units known as faveoli. This has led to sug-
gestions that a highly surface-active surfactant capa-
ble of attaining very low surface tensions may not be
critical for optimal lung function in these animals.
Certainly the larger size of the faveoli (100^1000
times larger than alveoli of similar sized mammals)
would avoid the high collapsing forces thought to
induce atelectasis (alveolar collapse) in the 50^100
Wm mammalian alveoli. Faveoli possess an enhanced
backbone consisting of elastin and collagen and an
inner trabecular system which supports and stabilizes
the inner connecting units [74].
These considerations have led to the suggestion
that surfactant has other functions in non-mamma-
lian vertebrates such as acting as an anti-adherent
(also known as an anti-glue) factor. A water droplet
between two glass microscope slides spreads readily
by capillary action because hydrophilic glass binds
water better than water binds itself. The surprisingly
high force required to separate wetted glass slides is
due to surface tension forces resisting expansion of
the air-water interface. Air-breathing ¢sh, some liz-
ards, snakes and amphibians can partially or com-
pletely degas their respiratory units [65,75]. Reopen-
ing the wet tissue surfaces of interfolded faveoli (or
collapsed alveoli) is greatly aided by reducing surface
tension to the equilibrium value of approx. 25 mN/
m. A similar phenomenon occurs with the ¢rst
breath in newborn mammals, where by reducing sur-
face tension surfactant facilitates lung expansion
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with air. It should be stressed there is no ‘glue’ for
the anti-glue factor to counter but only surface ten-
sion forces. The anti-glue function can be determined
by completely emptying the lungs of air and measur-
ing the pressure required to open the lungs before
and after lavage. In almost all species examined,
there is a greater opening pressure following surfac-
tant removal [65,75]. However, in control experi-
ments, where gut tissue is collapsed and in£ated be-
fore and after lavage, no such increase in opening
pressure is observed. Surfactants contributing to res-
piratory unit opening must adsorb rapidly at body
temperature, but this action is independent of the
surfactant’s ability to attain low surface tension dur-
ing compression. High cholesterol and low disatura-
tion should enhance adsorption and respreading at
low temperatures.
Another function suggested for both non-mamma-
lian and mammalian surfactants is that of an anti-
oedema factor [76]. It has been suggested this func-
tion could be important in birds which have minute
rigid air capillaries [73]. The theoretical basis of this
anti-oedema function is that water molecules at the
air-liquid interface experience lower average attrac-
tive forces into the bulk phase, resulting in a de-
creased pressure di¡erence across the interface, as
indicated by the Laplace equation. However, water
in the bulk phase would experience association with
ions and proteins as indicated by the Starling equa-
tions, and to date this anti-oedema function of sur-
factant has not been experimentally proven for nor-
mal mammalian lungs. Nevertheless, considerable
evidence is available for the ability of surfactant to
prevent £ooding of the lungs injured through surfac-
tant de¢ciency arising from prematurity, lavage, or
other insults which tend to increase serum protein
levels [19,76]. Thus it appears likely that pulmonary
surfactant could act synergistically with epithelial so-
dium channels to maintain wetted but not £ooded
alveoli [77].
7. Future directions
Since the rediscovery of pulmonary surfactant by
Pattle and Clements in the 1950s, information arising
from a number of scienti¢c disciplines has greatly
expanded our understanding. However, it is evident
a number of crucial details are still lacking. For ex-
ample, how is the DPPC-enriched monolayer gener-
ated during adsorption? What are the precise roles of
PC, PG, and possibly the other minor phospholipid
constituents in selective DPPC adsorption and in £u-
id lipid squeeze-out? What is the exact composition
of the interfacial ¢lm and what structures does it
adopt? Does cholesterol contribute to selective
DPPC adsorption in the lung? Is cholesterol ex-
cluded from the surface, as appears likely, and if
so, how does this occur? What is the mechanism
by which surfactant desorbs from the interface and
what controls its return to the type II cells and the
subsequent cellular re-uptake?
Are the minor lipid components, the major lipid
components, or the surfactant apoproteins involved
in signal transduction processes responsible for con-
trolling alveolar surfactant levels? Are surfactant lip-
ids involved in other signalling events?
What is the reason for the di¡erences in neutral
lipid content between mammalian species, and what
is the signi¢cance of the observed alterations in al-
veolar cholesterol content during activity? Why do
some non-mammalian species have surfactants with
very similar phospholipid pro¢les, but di¡erent cho-
lesterol/disaturation patterns? Do non-mammalian
surfactants lower surface tension in the faveoli to
low values like mammalian surfactants?
We anticipate these and other issues will keep sci-
entists in many disciplines occupied for a consider-
able time. We speculate that, during these investiga-
tions, they may discover other important biological
functions for surfactant still not suspected. We pre-
dict a better understanding of surfactant function
will prove valuable not only in contributing to our
understanding of the biology of surfactant, but also
as a basis for important improvements in therapy for
a number of respiratory diseases.
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